Mass spectrometry imaging for glycome in the brain

MM Hasan, MA Mimi, MA Mamun, A Islam… - Frontiers in …, 2021 - frontiersin.org
Glycans are diverse structured biomolecules that play crucial roles in various biological
processes. Glycosylation, an enzymatic system through which various glycans are bound to …

Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders

A Wang, C Chen, C Mei, S Liu, C Xiang, W Fang… - Nature Cell …, 2024 - nature.com
Lysosomal storage disorders (LSDs), which are characterized by genetic and metabolic
lysosomal dysfunctions, constitute over 60 degenerative diseases with considerable health …

α-Mannosidase and β-d-N-acetylhexosaminidase outside the wall: partner exoglycosidases involved in fruit ripening process

L Morales-Quintana, A Méndez-Yáñez - Plant Molecular Biology, 2023 - Springer
Cell wall is a strong and complex net whose function is to provide turgor, pathogens attack
protection and to give structural support to the cell. In growing and expanding cells, the cell …

Bis (monoacylglycero) phosphate, a new lipid signature of endosome-derived extracellular vesicles

M Rabia, V Leuzy, C Soulage, A Durand, B Fourmaux… - Biochimie, 2020 - Elsevier
Abstract Bis (monoacylglycero) phosphate (BMP), also known as lysobisphosphatidic acid
(LBPA), is a phospholipid specifically enriched in the late endosome-lysosome compartment …

Brain endothelial specific gene therapy improves experimental Sandhoff disease

G Dogbevia, H Grasshoff, A Othman… - Journal of Cerebral …, 2020 - journals.sagepub.com
In Tay-Sachs and Sandhoff disease, a deficiency of the lysosomal enzyme β-
hexosaminidase causes GM2 and other gangliosides to accumulate in neurons and triggers …

Treating late-onset Tay Sachs disease: Brain delivery with a dual trojan horse protein

E Osher, Y Anis, R Singer-Shapiro, N Urshanski… - … Therapy Methods & …, 2024 - cell.com
Tay-Sachs (TS) disease is a neurodegenerative disease resulting from mutations in the
gene encoding the α-subunit (HEXA) of lysosomal β-hexosaminidase A (HexA). We report …

Substrate reduction therapy for sandhoff disease through inhibition of glucosylceramide synthase activity

J Marshall, JB Nietupski, H Park, J Cao, DS Bangari… - Molecular Therapy, 2019 - cell.com
Neuronopathic glycosphingolipidoses are a sub-group of lysosomal storage disorders for
which there are presently no effective therapies. Here, we evaluated the potential of …

Double prenylation of SNARE protein Ykt6 is required for lysosomal hydrolase trafficking

N Sakata, R Shirakawa, K Goto… - The journal of …, 2021 - academic.oup.com
Ykt6 is an evolutionarily conserved SNARE protein regulating Golgi membrane fusion and
other diverse membrane trafficking pathways. Unlike most SNARE proteins, Ykt6 lacks a …

Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model

ME Lopez, D Wendt, R Lawrence, K Gong, H Ong… - PloS one, 2025 - journals.plos.org
The GM2 gangliosidoses, Tay-Sachs disease and Sandhoff disease, are devastating
neurodegenerative disorders caused by β-hexosaminidase A (HexA) deficiency. In the …

Lysoglycosphingolipids have the ability to induce cell death through direct PI3K inhibition

R Watanabe, D Tsuji, H Tanaka, MS Uno… - Journal of …, 2023 - Wiley Online Library
Sphingolipidoses are inherited metabolic disorders associated with glycosphingolipids
accumulation, neurodegeneration, and neuroinflammation leading to severe neurological …